Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
-
A3405 EtoricoxibSummary: Specific COX-2 inhibitor
-
A3416 FK 3311Summary: Selective COX-2 inhibitor
-
A3484 IguratimodSummary: COX-2 inhibitor,inhibits IL-1,IL-6,IL-8 and tumour necrosis factor.
-
B1459 ValdecoxibTarget: COXSummary: COX-2 inhibitor
-
B1454 RofecoxibTarget: COXSummary: COX-2 inhibitor
-
B1239 Parecoxib SodiumSummary: COX-2 inhibitor
-
B1091 DeracoxibSummary: Selective COX-2 inhibitor
-
B1444 EtodolacSummary: COX-2 inhibitor
-
B1018 (S)-(+)-IbuprofenSummary: COX inhibitor
-
B2044 SulindacSummary: Anti-inflammatory agent;COX inhibitor